Platelet profile in patients with acute bacterial skin and skin structure infections receiving tedizolid or linezolid: findings from the Phase 3 ESTABLISH clinical trials.
about
New developments in the management of severe skin and deep skin structure infections - focus on tedizolidPharmacokinetic drug evaluation of tedizolid for the treatment of skin infections.Nonclinical and pharmacokinetic assessments to evaluate the potential of tedizolid and linezolid to affect mitochondrial functionProfile of tedizolid phosphate and its potential in the treatment of acute bacterial skin and skin structure infectionsTedizolid: a novel oxazolidinone with potent activity against multidrug-resistant gram-positive pathogens.Characterization of the haematological profile of 21 days of tedizolid in healthy subjects.Tedizolid: The First Once-Daily Oxazolidinone Class Antibiotic.Multidrug-resistant Enterobacteriaceae, Pseudomonas aeruginosa, and vancomycin-resistant enterococci: Three major threats to hematopoietic stem cell transplant recipients.Diagnosis and management of skin and soft-tissue infections (SSTI). A literature review and consensus statement: an update.Correction of myelotoxicity after switch of linezolid to tedizolid for prolonged treatments.Dosing strategies to optimize currently available anti-MRSA treatment options (Part 2: PO options).Thrombocytopenia with Tedizolid and Linezolid.Pharmacokinetics of Tedizolid and Pseudoephedrine Administered Alone or in Combination in Healthy Volunteers.
P2860
Q28083116-899A4FDF-7E37-45DB-853A-5BC3ED58FB60Q33438834-F463F67D-A978-4937-9EC3-EE93F7390CBAQ34922189-0E3285EB-910A-4B78-99F2-3A01C1E54E6FQ35542330-C3532592-6791-4C09-8F28-0E7577DD66FBQ38352171-06E16E10-844E-4BBE-A1A1-7E4A4CA43695Q38391120-2F928643-041D-424D-AEB7-631E322501FDQ38536296-3D87D6EF-7785-4505-9D10-A8B63A1BC3C1Q38620812-E8E2C991-7897-4DF7-AC6C-64E99CE3CD4EQ38853784-62731BFB-7114-494C-B3CE-9134A349F1E8Q40267578-6C862365-47DA-43F6-A3AB-5D8005BC29DFQ47396324-6869B854-751A-4EF0-9C26-08A927CE19CDQ47737103-DE16DFCA-A460-4AB0-B6B6-0B803F48C183Q55511795-4D654E1F-456A-4F2F-BC33-DFDB76F8F0C7
P2860
Platelet profile in patients with acute bacterial skin and skin structure infections receiving tedizolid or linezolid: findings from the Phase 3 ESTABLISH clinical trials.
description
2014 nî lūn-bûn
@nan
2014 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
name
Platelet profile in patients w ...... e 3 ESTABLISH clinical trials.
@ast
Platelet profile in patients w ...... e 3 ESTABLISH clinical trials.
@en
type
label
Platelet profile in patients w ...... e 3 ESTABLISH clinical trials.
@ast
Platelet profile in patients w ...... e 3 ESTABLISH clinical trials.
@en
prefLabel
Platelet profile in patients w ...... e 3 ESTABLISH clinical trials.
@ast
Platelet profile in patients w ...... e 3 ESTABLISH clinical trials.
@en
P2093
P2860
P356
P1476
Platelet profile in patients w ...... e 3 ESTABLISH clinical trials.
@en
P2093
Edward Fang
Philippe G Prokocimer
Sonia L Minassian
Thomas P Lodise
P2860
P304
P356
10.1128/AAC.03509-14
P407
P577
2014-09-22T00:00:00Z